We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Magnetic Resonance Imaging (MRI) Halves Risk of Prostate Cancer Overdiagnosis

By MedImaging International staff writers
Posted on 09 Dec 2022
Print article
Image: New prostate cancer diagnostic pathway paves way for general screening (Photo courtesy of Pexels)
Image: New prostate cancer diagnostic pathway paves way for general screening (Photo courtesy of Pexels)

A major problem in screening for prostate cancer is that a very high proportion of the cancer cases detected represent small, usually harmless tumors. This carries a risk of many men being treated unnecessarily, with the associated risk of permanent complications in the form of urinary incontinence and impotence - effects that adversely affect their quality of life. Now, a new study has shown that the risk of overdiagnosis can be halved in screening for prostate cancer. With the diagnostic pathway that has now been tried out, considerably fewer harmless tumors are found. This solves a big problem and makes general screening feasible.

In the present study, researchers at the University of Gothenburg (Gothenburg, Sweden) invited 37,887 men in Sweden aged 50–60 years to take the prostate-specific antigen (PSA) blood test. In the event of their PSA levels being elevated, they were offered magnetic resonance imaging (MRI) of the prostate. The 17,980 men who took part (47% of all invitees) were divided into two groups. In the reference group, all those with elevated PSA levels ​​were offered systematic tissue sampling, with 12 “blind” tissue samples taken from various parts of the prostate. If the MRI showed anything suspicious, another three or four targeted tissue samples were taken in the area concerned. Today this strategy is, broadly speaking, standard worldwide.

In the experimental group, only men with suspicious findings revealed by MRI were selected for tissue sampling. Four targeted tissue samples only were taken in the area of suspicion. The results show that the risk of finding an indolent (harmless) cancer was halved in the experimental group, while serious, potentially deadly cancers were found on an almost equal scale in both groups. In the experimental group, there was a greater probability that detection of a moderately severe cancer would be slightly delayed in a small proportion of individuals. Nevertheless, the overall result indicates that there are now sound medical arguments for introducing screening in line with the current model.

“We must get away from the blind sampling of tissues that’s still standard today, rely on the MRI examination, and thus switch diagnostics to taking samples only in those men in whom MRI has depicted tumors - and then only do targeted samples in the area involved,” said Jonas Hugosson, Professor of Urology at the University of Gothenburg and senior physician at Sahlgrenska University Hospital, who was in charge of the study. “This strategy is sharply reducing the number of people who need to undergo tissue sampling, which is an unpleasant procedure with an associated risk of infection. What’s more, the strategy halves the risk of detecting a harmless tumor, which has been the biggest obstacle to introducing general screening for prostate cancer.”

“The results from this study can pave the way for the introduction of general screening for prostate cancer. But assessment must include also other factors, such as costs and access to MRI scans,” Hugosson concluded.

Related Links:
University of Gothenburg 

New
Gold Supplier
Portable X-Ray System
FDR Xair
New
Densitometry & Data Management Solution
QuickScan Touch Plus
New
DICOM Cloud Solution
ORCA Archive
New
CR Scanner
ExamVue CR PRO

Print article
Sun Nuclear -    Mirion
FIME - Informa

Channels

Radiography

view channel
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)

Sustainable Solar Cell Material Could Revolutionize Medical Imaging

The use of X-rays for internal body imaging has dramatically changed non-invasive medical diagnostics. Yet, the high dose of X-rays required for these imaging techniques, due to the poor performance of... Read more

Ultrasound

view channel
Image: A novel, skull-implantable ultrasound device can open the blood-brain barrier to deliver chemotherapy (Photo courtesy of Northwestern Medicine)

Skull-Implantable Ultrasound Device Enables Powerful Chemotherapy Drug to Reach Brain Tumors

A significant challenge in treating lethal brain cancer known as glioblastoma has been the inability of powerful chemotherapy to penetrate the blood-brain barrier to target the aggressive brain tumor.... Read more

Nuclear Medicine

view channel
Image: The components of the dosimeter can fit into an 18mm by 7mm capsule (Photo courtesy of University of NUS)

Novel Ingestible Capsule X-Ray Dosimeter Enables Real-Time Radiotherapy Monitoring

Gastric cancer ranks among the most prevalent cancers worldwide. Precision is vital in modern radiotherapy, as it aims to target tumor cells while minimizing damage to healthy tissue. However, challenges... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.